Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
GW Pharmaceuticals said on Thursday that it has started the second of two Phase 3 trials of Epidiolex, which is used for the treatment of Lennox-Gasta...
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE